Research Paper Volume 12, Issue 1 pp 611—627
Aspirin enhances the sensitivity of colon cancer cells to cisplatin by abrogating the binding of NF-κB to the COX-2 promoter
Figure 7. The schematic of the molecular mechanisms involved in the synergistic anti-tumor effect of Aspirin and Cisplatin in colon cancer. Aspirin in combination with Cisplatin enhanced the inhibition of cell proliferation, migration and invasion by reducing COX-2 mediated prostaglandin E2 synthesis and attenuating downstream PI3K/AKT, RAF-MEK-ERK and NF-κB/COX-2 signaling activities. Meanwhile, combination with Aspirin and Cisplatin could induce more apoptosis through triggering cytochrome-c release.